Ovarian Cancer

Thursday, September 15, 2016 - 2:49pm

An ovarian cancer test, CA125 is a reliable tool when used correctly. That is the message from Roswell Park following an FDA alert regarding the use of this common blood test.

Thursday, June 30, 2016 - 4:25pm

If you are considering starting a clinical trial, either because your doctor recommended it or because you or an advocate found a trial that seems appropriate, I have this easy advice: “GO FOR IT!” What have you got to lose? Trials are safe, well researched and documented. You, as a patient, are monitored and cared for like you never thought possible. You have so much to gain!

Tuesday, June 28, 2016 - 3:52pm

“Happy birthday to me.” KayEllen Gebhart says this in a flat voice, recalling her birthday in 2008 — the day she learned she had stage III ovarian cancer. The bad news came after a CT scan to find out what was causing the “tummy issues” her family doctor thought might be caused by her gallbladder.

Monday, September 21, 2015 - 2:52pm

Delivering chemotherapy directly to the abdomen can significantly improve survival among women with ovarian cancer—so significantly that nearly ten years ago, the National Cancer Institute issued a special clinical announcement urging oncologists to use the approach, called intraperitonea

Thursday, September 17, 2015 - 3:23pm

While an estimated 5 to 10 percent of all cancers are due to hereditary factors, ovarian cancer is unique—up to 25 percent of these cancers are thought to have a hereditary cause.

Tuesday, May 26, 2015 - 9:10am

Growing up as the daughter of two physicians in Budapest, Hungary, Emese Zsiros, MD, PhD, FACOG, recognized her passion for medicine at an early age. She earned a combined MD/PhD at one of the top medical schools in Europe before heading to the United States to complete her OB/GYN residency.

Wednesday, October 16, 2013 - 11:11am

Roswell Park Cancer Institute (RPCI) and the University of Pittsburgh Cancer Institute (UPCI) were recently awarded an $11 million Ovarian Cancer Specialized Program of Research Excellence (SPORE) grant.

Monday, September 23, 2013 - 2:34pm

Women with a strong family history of breast and ovarian cancer have an increased risk of developing these diseases. Sometimes this strong family history indicates a BRCA1 or BRCA2 gene mutation, making the odds of developing these cancers even higher.

Tuesday, June 18, 2013 - 2:26pm

The U.S. Supreme Court's unanimous ruling — that companies may no longer patent human genes — resonated across the cancer community, resulting in promising news for cancer patients and researchers.

Monday, June 10, 2013 - 12:19pm

We asked some of Roswell Park’s doctors who specialize in cancers that affect women to share some tips for preventing or treating cancer. Here’s what they offered.